- Home
- PSTL vs TECX Comparison
PSTL vs TECX Comparison
Compare PSTL & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTL
- TECX
- Stock Information
- Founded
- PSTL 2018
- TECX 2019
- Country
- PSTL United States
- TECX United States
- Employees
- PSTL N/A
- TECX N/A
- Industry
- PSTL Real Estate Investment Trusts
- TECX
- Sector
- PSTL Real Estate
- TECX
- Exchange
- PSTL Nasdaq
- TECX Nasdaq
- Market Cap
- PSTL 329.8M
- TECX 387.1M
- IPO Year
- PSTL 2019
- TECX 2018
- Fundamental
- Price
- PSTL $14.56
- TECX $23.51
- Analyst Decision
- PSTL Strong Buy
- TECX Strong Buy
- Analyst Count
- PSTL 1
- TECX 5
- Target Price
- PSTL $17.75
- TECX $79.00
- AVG Volume (30 Days)
- PSTL 135.5K
- TECX 233.4K
- Earning Date
- PSTL 08-04-2025
- TECX 08-07-2025
- Dividend Yield
- PSTL 6.66%
- TECX N/A
- EPS Growth
- PSTL 344.13
- TECX N/A
- EPS
- PSTL 0.39
- TECX N/A
- Revenue
- PSTL $86,535,000.00
- TECX N/A
- Revenue This Year
- PSTL $19.86
- TECX N/A
- Revenue Next Year
- PSTL $10.14
- TECX N/A
- P/E Ratio
- PSTL $37.61
- TECX N/A
- Revenue Growth
- PSTL 26.43
- TECX N/A
- 52 Week Low
- PSTL $12.26
- TECX $13.70
- 52 Week High
- PSTL $15.42
- TECX $61.07
- Technical
- Relative Strength Index (RSI)
- PSTL 51.11
- TECX 56.50
- Support Level
- PSTL $14.29
- TECX $21.31
- Resistance Level
- PSTL $14.88
- TECX $23.12
- Average True Range (ATR)
- PSTL 0.30
- TECX 1.53
- MACD
- PSTL 0.04
- TECX 0.13
- Stochastic Oscillator
- PSTL 75.19
- TECX 71.85
About PSTL Postal Realty Trust Inc.
Postal Realty Trust Inc is an internally managed real estate corporation that owns and manages properties leased to the United States Postal Service, or the USPS. Its objective is to create stockholder value by generating risk-adjusted returns through expanding its portfolio of owned and managed postal properties leased to the USPS. The majority of the revenue is generated from the rental income received.
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.